| Literature DB >> 31753806 |
Kathryn J Snow1, Andrea T Cruz2, James A Seddon3, Rashida A Ferrand4, Silvia S Chiang5, Jennifer A Hughes6, Beate Kampmann7, Steve M Graham8, Peter J Dodd9, Rein M Houben10, Justin T Denholm11, Susan M Sawyer12, Katharina Kranzer13.
Abstract
Adolescence is characterised by a substantial increase in the incidence of tuberculosis, a known fact since the early 20th century. Most of the world's adolescents live in low-income and middle-income countries where tuberculosis remains common, and where they comprise a quarter of the population. Despite this, adolescents have not yet been addressed as a distinct population in tuberculosis policy or within tuberculosis treatment services, and emerging evidence suggests that current models of care do not meet their needs. This Review discusses up-to-date information about tuberculosis in adolescence, with a focus on the management of infection and disease, including HIV co-infection and rifampicin-resistant tuberculosis. We outline the progress in vaccine development and highlight important directions for future research.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31753806 PMCID: PMC7291359 DOI: 10.1016/S2352-4642(19)30337-2
Source DB: PubMed Journal: Lancet Child Adolesc Health ISSN: 2352-4642